IQVIA HOLDINGS INC. Reimbursement Revenue (Deprecated 2018-01-31)
IQVIA HOLDINGS INC. (IQV) reported Reimbursement Revenue (Deprecated 2018-01-31) of $1.68 billion for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-16.
Discontinued › Income Statement › Other Income
us-gaap:ReimbursementRevenue · last filed 2018-02-16
- IQVIA HOLDINGS INC. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $416.00M, a 7.77% increase year-over-year.
- IQVIA HOLDINGS INC. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $446.00M, a 23.89% increase year-over-year.
- IQVIA HOLDINGS INC. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $406.00M, a 5.18% increase year-over-year.
- IQVIA HOLDINGS INC. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $411.00M, a 7.59% increase year-over-year.
- IQVIA HOLDINGS INC. reimbursement revenue (deprecated 2018-01-31) for fiscal 2017 was $1.68B, a 10.90% increase from fiscal 2016.
- IQVIA HOLDINGS INC. reimbursement revenue (deprecated 2018-01-31) for fiscal 2016 was $1.51B, a 7.30% increase from fiscal 2015.
- IQVIA HOLDINGS INC. reimbursement revenue (deprecated 2018-01-31) for fiscal 2015 was $1.41B, a 8.96% increase from fiscal 2014.
- IQVIA HOLDINGS INC. reimbursement revenue (deprecated 2018-01-31) for fiscal 2014 was $1.29B, a 0.29% increase from fiscal 2013.
| Period end | Reimbursement Revenue (Deprecated 2018-01-31) 3 month | Reimbursement Revenue (Deprecated 2018-01-31) 3 month as first filed | Reimbursement Revenue (Deprecated 2018-01-31) 6 month | Reimbursement Revenue (Deprecated 2018-01-31) 6 month as first filed | Reimbursement Revenue (Deprecated 2018-01-31) 9 month | Reimbursement Revenue (Deprecated 2018-01-31) 9 month as first filed | Reimbursement Revenue (Deprecated 2018-01-31) 12 month | Reimbursement Revenue (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $416.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $862.00M derived: sum of 2 quarters · filed 2018-02-16 | $1.27B derived: sum of 3 quarters · filed 2018-02-16 | $1.68B 10-K · filed 2018-02-16 | ||||
| 2017-09-30 | $446.00M 10-Q · filed 2017-10-27 | $852.00M derived: sum of 2 quarters · filed 2017-10-27 | $1.26B 10-Q · filed 2017-10-27 | $1.65B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2017-06-30 | $406.00M 10-Q · filed 2017-08-04 | $817.00M 10-Q · filed 2017-08-04 | $1.20B derived: sum of 3 quarters · filed 2018-02-16 | $1.56B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2017-03-31 | $411.00M 10-Q · filed 2017-05-08 | $797.00M derived: sum of 2 quarters · filed 2018-02-16 | $1.16B derived: sum of 3 quarters · filed 2018-02-16 | $1.54B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-12-31 | $386.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $746.00M derived: sum of 2 quarters · filed 2018-02-16 | $1.13B derived: sum of 3 quarters · filed 2018-02-16 | $1.51B 10-K · filed 2018-02-16 | ||||
| 2016-09-30 | $360.00M 10-Q · filed 2017-10-27 | $360.75M 10-Q · filed 2016-11-03 | $746.00M derived: sum of 2 quarters · filed 2017-10-27 | $1.13B 10-Q · filed 2017-10-27 | $1.13B 10-Q · filed 2016-11-03 | $1.52B derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-06-30 | $386.00M 10-Q · filed 2017-08-04 | $385.61M 10-Q · filed 2016-07-27 | $768.00M 10-Q · filed 2017-08-04 | $767.67M 10-Q · filed 2016-07-27 | $1.16B derived: sum of 3 quarters · filed 2018-02-16 | $1.49B derived: sum of 4 quarters · filed 2018-02-16 | ||
| 2016-03-31 | $382.00M 10-Q · filed 2017-05-08 | $382.06M 10-Q · filed 2016-05-03 | $774.93M derived: sum of 2 quarters · filed 2018-02-16 | $1.11B derived: sum of 3 quarters · filed 2018-02-16 | $1.48B derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | $392.93M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $724.22M derived: sum of 2 quarters · filed 2018-02-16 | $1.09B derived: sum of 3 quarters · filed 2018-02-16 | $1.41B 10-K · filed 2018-02-16 | $1.41B 10-K · filed 2016-02-11 | |||
| 2015-09-30 | $331.29M 10-Q · filed 2016-11-03 | $700.45M derived: sum of 2 quarters · filed 2016-11-03 | $1.02B 10-Q · filed 2016-11-03 | $1.37B derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | $369.16M 10-Q · filed 2016-07-27 | $686.78M 10-Q · filed 2016-07-27 | $1.03B derived: sum of 3 quarters · filed 2017-02-16 | $1.37B derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | $317.62M 10-Q · filed 2016-05-03 | $665.49M derived: sum of 2 quarters · filed 2017-02-16 | $1.00B derived: sum of 3 quarters · filed 2017-02-16 | $1.31B derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | $347.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $686.89M derived: sum of 2 quarters · filed 2017-02-16 | $992.44M derived: sum of 3 quarters · filed 2017-02-16 | $1.29B 10-K · filed 2017-02-16 | $1.29B 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $339.02M 10-Q · filed 2015-10-28 | $644.58M derived: sum of 2 quarters · filed 2015-10-28 | $947.13M 10-Q · filed 2015-10-28 | $1.32B derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | $305.55M 10-Q · filed 2015-07-29 | $608.11M 10-Q · filed 2015-07-29 | $983.36M derived: sum of 3 quarters · filed 2016-02-11 | $1.25B derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | $302.56M 10-Q · filed 2015-04-29 | $677.80M derived: sum of 2 quarters · filed 2016-02-11 | $940.91M derived: sum of 3 quarters · filed 2016-02-11 | $1.29B derived: sum of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | $375.25M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $638.36M derived: sum of 2 quarters · filed 2016-02-11 | $989.80M derived: sum of 3 quarters · filed 2016-02-11 | $1.29B 10-K · filed 2016-02-11 | ||||
| 2013-09-30 | $263.11M 10-Q · filed 2014-10-30 | $614.55M derived: sum of 2 quarters · filed 2014-10-30 | $915.96M 10-Q · filed 2014-10-30 | $1.25B derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | $351.44M 10-Q · filed 2014-07-31 | $652.85M 10-Q · filed 2014-07-31 | $985.67M derived: sum of 3 quarters · filed 2015-02-12 | $1.27B derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | $301.41M 10-Q · filed 2014-05-01 | $634.23M derived: sum of 2 quarters · filed 2015-02-12 | $920.22M derived: sum of 3 quarters · filed 2015-02-12 | $1.21B derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | $332.83M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $618.81M derived: sum of 2 quarters · filed 2015-02-12 | $904.67M derived: sum of 3 quarters · filed 2015-02-12 | $1.17B 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | $285.99M 10-Q · filed 2013-10-31 | $571.84M derived: sum of 2 quarters · filed 2013-10-31 | $840.39M 10-Q · filed 2013-10-31 | |||||
| 2012-06-30 | $285.85M 10-Q · filed 2013-08-01 | $554.40M 10-Q · filed 2013-08-01 | ||||||
| 2012-03-31 | $268.55M 10-Q · filed 2013-05-14 | |||||||
| 2011-12-31 | $1.03B 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |